» Authors » Nicola S Fearnhead

Nicola S Fearnhead

Explore the profile of Nicola S Fearnhead including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 513
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Lamidi S, Williams K, Blackwell S, Rashid A, Coe P, et al.
J Clin Epidemiol . 2024 Jul; 174:111470. PMID: 39038745
Background: Inconsistent reporting of patient characteristics in clinical research hampers reproducibility and limits analysis opportunities. This paper proposes condition-specific 'Core Descriptor Sets' comprising key factors like demographics, disease severity, comorbidities,...
2.
Boyle J, Kuryba A, Blake H, van der Meulen J, Fearnhead N, Braun M, et al.
Colorectal Dis . 2024 Feb; 26(3):486-496. PMID: 38302858
Aim: Evidence is lacking on whether there were inequalities in the recovery of colorectal cancer (CRC) services within the English National Health Service (NHS) following the COVID-19 pandemic. The aim...
3.
Blake H, Sharples L, Boyle J, Kuryba A, Moonesinghe S, Murray D, et al.
Int J Surg . 2024 Jan; 110(3):1564-1576. PMID: 38285065
Background: Life-saving emergency major resection of colorectal cancer (CRC) is a high-risk procedure. Accurate prediction of postoperative mortality for patients undergoing this procedure is essential for both healthcare performance monitoring...
4.
Boyle J, van der Meulen J, Kuryba A, Cowling T, Braun M, Aggarwal A, et al.
Colorectal Dis . 2023 Sep; 25(10):1981-1993. PMID: 37705203
Aim: Evidence for a positive volume-outcome relationship for rectal cancer surgery is unclear. This study aims to evaluate the volume-outcome relationship for rectal cancer surgery at hospital and surgeon level...
5.
Simillis C, Khatri A, Dai N, Afxentiou T, Jephcott C, Smith S, et al.
Crit Rev Oncol Hematol . 2023 Jan; 183:103927. PMID: 36706968
Aim: Multiple neoadjuvant therapy strategies have been used and compared for rectal cancer and there has been no true consensus as to the optimal neoadjuvant therapy regimen. The aim is...
6.
Boyle J, van der Meulen J, Kuryba A, Cowling T, Booth C, Fearnhead N, et al.
Eur J Cancer . 2022 Dec; 178:191-204. PMID: 36459767
Aim: To date, there has been little systematic assessment of the quality of care associated with systemic anti-cancer therapy (SACT) delivery across national healthcare systems. We evaluated hospital-level toxicity rates...
7.
Harji D, Williams A, McKigney N, Boissieras L, Denost Q, Fearnhead N, et al.
Eur J Surg Oncol . 2022 Aug; 48(11):2238-2249. PMID: 36030134
Background: Shared decision-making in pelvic exenteration is a complex and detailed process, which must balance clinical, oncological and patient-reported outcomes (PROs), whilst addressing and valuing the patient priorities. Communicating patient-centred...
8.
Simillis C, Taylor B, Ahmad A, Lal N, Afxentiou T, Powar M, et al.
Eur J Cancer . 2022 Jul; 172:237-251. PMID: 35797761
Background: The impact of body mass index (BMI) on long-term survival outcomes after colorectal cancer surgery is debated. Design: A systematic literature review and meta-analysis was performed to compare long-term...
9.
Fearnhead N
Surgery . 2022 Jun; 172(3):789-790. PMID: 35660021
No abstract available.
10.
Yeow M, Soh S, Wong J, Koh F, Syn N, Fearnhead N, et al.
Br J Surg . 2022 May; 109(10):900-903. PMID: 35640279
No abstract available.